Zoledronic acid

Zoledronic acid Reactions 1680, p345 - 2 Dec 2017 and knees. Immediately after the infusion, she developed worsening pain of lower limbs, with tenderness over both quadriceps. Two months after the zoledronic acid infusion, she had restriction of bilateral shoulder movements. She showed a Various toxicities: 6 case reports CRP of 100 mg/L and was subsequently diagnosed with PMR. In a retrospective case-series study, six women aged She started receiving treatment with unspecified systemic 58 84 years were described, who developed flare-up of steroids and methotrexate. arthralgia and tenosynovitis (1 woman), flu-like symptoms, Author comment: "Six patients experienced new-onset or new-onset erythema and worsening of arthralgia (1 woman), marked deterioration of immune-mediated syndromes vomiting, syncopal episode and rheumatoid arthritis (RA) temporally associated with zoledronate infusion". (1 woman), polymyalgia rheumatica (PMR) (2 women), and acquired autoimmune haemophilia and immediate muscle Markovits N, et al. Immune-mediated syndromes following intravenous pain (1 woman), following the administration of zoledronic bisphosphonate therapy. Inflammopharmacology 25: 665-671, No. 6, Dec 2017. Available from: URL: http://doi.org/10.1007/s10787-017-0365-9 - acid [zoledronate; dosages not stated; not all outcomes stated]. Israel 803284863 The 68-year-old woman developed flare-up of arthralgia and synovitis, following the administration of zoledronic acid. She had a history of lumpectomy for breast cancer and unspecified aromatase inhibitor-induced arthralgia. She also had osteoporosis, for which she started receiving IV infusion of zoledronic acid. One day after the infusion, she developed swelling and flexion restriction of right hand fingers and rd tenosynovitis of 3 right flexor tendon. Two months following zoledronic acid infusion, she showed persistent tenderness rd over 3 right flexor tendon and requiring treatment with an unspecified local steroid injection. An ultrasound revealed rd persistent synovitis of the bilateral 3 metacarpophalangeals (MCPs). The 58-year-old woman developed flu-like symptoms, new- onset erythema and worsening of arthralgia following the administration of zoledronic acid. She had a history of Crohn’s disease and persistent arthralgia of large and small joints. She also had osteoporosis, for which she started receiving IV infusion of zoledronic acid. Immediately after the infusion, she developed flu like symptoms, new-onset erythema over proximal interphalangeals (PIPs) and worsening of joint pain, with bilateral tenderness over PIPs and distal interphalangeals (DIPs). After 3 weeks of receiving the zoledronic acid, she showed persistent worsening of arthralgia. The flu like symptoms and erythema lasted for 10 days. The 75-year-old woman developed vomiting, syncopal episode and RA, following the administration of zoledronic acid. She started receiving IV infusion of zoledronic acid for osteoporosis. One day after the infusion, she developed fever, vomiting and syncopal episode. She developed severe pain and flexion limitation of fingers, with tenderness and slight rd th swelling of bilateral 3 MCPs and 4 PIPs. She also had rd tenderness and swelling of the right 3 MTP. Within a year of receiving zoledronic acid, she developed recurrent episodes of hand and feet arthritis, with swollen bilateral MCPs. A hand x- ray showed results indicative of RA and there was presence of high titer of rheumatoid factor and anti-Ro antibodies. Subsequently, she started receiving treatment with methotrexate. The 83-year-old woman developed PMR following the administration of zoledronic acid. She had a history of colectomy for colon carcinoma. She also had osteoporosis, for which she started receiving IV infusion of zoledronic acid. One week following the administration of the IV infusion, she developed pain in both shoulders, spreading to arms, knees and hips, and was treated with unspecified systemic steroids. Several weeks after receiving the zoledronic acid, she showed musculoskeletal pain with ESR of 120 mm/hour. Subsequently, she was diagnosed with PMR. The 84-year-old woman developed autoimmune acquired haemophilia and immediate muscle pain, following the administration of zoledronic acid. She was recently diagnosed with breast cancer and started receiving IV infusion of zoledronic acid for osteoporosis. Immediately, she developed muscle pain which lasted for 9 days. Two months after the zoledronic acid infusion, she developed autoimmune acquired haemophilia and was treated with unspecified high dose corticosteroids. The 69-year-old woman developed PMR following the administration of zoledronic acid. She started receiving IV infusion of zoledronic acid for painful osteoarthritis of hands 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Zoledronic acid

Reactions Weekly , Volume 1680 (1) – Dec 2, 2017
Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/zoledronic-acid-q6wfiP2itK
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-017-39276-0
Publisher site
See Article on Publisher Site

Abstract

Reactions 1680, p345 - 2 Dec 2017 and knees. Immediately after the infusion, she developed worsening pain of lower limbs, with tenderness over both quadriceps. Two months after the zoledronic acid infusion, she had restriction of bilateral shoulder movements. She showed a Various toxicities: 6 case reports CRP of 100 mg/L and was subsequently diagnosed with PMR. In a retrospective case-series study, six women aged She started receiving treatment with unspecified systemic 58 84 years were described, who developed flare-up of steroids and methotrexate. arthralgia and tenosynovitis (1 woman), flu-like symptoms, Author comment: "Six patients experienced new-onset or new-onset erythema and worsening of arthralgia (1 woman), marked deterioration of immune-mediated syndromes vomiting, syncopal episode and rheumatoid arthritis (RA) temporally associated with zoledronate infusion". (1 woman), polymyalgia rheumatica (PMR) (2 women), and acquired autoimmune haemophilia and immediate muscle Markovits N, et al. Immune-mediated syndromes following intravenous pain (1 woman), following the administration of zoledronic bisphosphonate therapy. Inflammopharmacology 25: 665-671, No. 6, Dec 2017. Available from: URL: http://doi.org/10.1007/s10787-017-0365-9 - acid [zoledronate; dosages not stated; not all outcomes stated]. Israel 803284863 The 68-year-old woman developed flare-up of arthralgia and synovitis, following the administration of zoledronic acid. She had a history of lumpectomy for breast cancer and unspecified aromatase inhibitor-induced arthralgia. She also had osteoporosis, for which she started receiving IV infusion of zoledronic acid. One day after the infusion, she developed swelling and flexion restriction of right hand fingers and rd tenosynovitis of 3 right flexor tendon. Two months following zoledronic acid infusion, she showed persistent tenderness rd over 3 right flexor tendon and requiring treatment with an unspecified local steroid injection. An ultrasound revealed rd persistent synovitis of the bilateral 3 metacarpophalangeals (MCPs). The 58-year-old woman developed flu-like symptoms, new- onset erythema and worsening of arthralgia following the administration of zoledronic acid. She had a history of Crohn’s disease and persistent arthralgia of large and small joints. She also had osteoporosis, for which she started receiving IV infusion of zoledronic acid. Immediately after the infusion, she developed flu like symptoms, new-onset erythema over proximal interphalangeals (PIPs) and worsening of joint pain, with bilateral tenderness over PIPs and distal interphalangeals (DIPs). After 3 weeks of receiving the zoledronic acid, she showed persistent worsening of arthralgia. The flu like symptoms and erythema lasted for 10 days. The 75-year-old woman developed vomiting, syncopal episode and RA, following the administration of zoledronic acid. She started receiving IV infusion of zoledronic acid for osteoporosis. One day after the infusion, she developed fever, vomiting and syncopal episode. She developed severe pain and flexion limitation of fingers, with tenderness and slight rd th swelling of bilateral 3 MCPs and 4 PIPs. She also had rd tenderness and swelling of the right 3 MTP. Within a year of receiving zoledronic acid, she developed recurrent episodes of hand and feet arthritis, with swollen bilateral MCPs. A hand x- ray showed results indicative of RA and there was presence of high titer of rheumatoid factor and anti-Ro antibodies. Subsequently, she started receiving treatment with methotrexate. The 83-year-old woman developed PMR following the administration of zoledronic acid. She had a history of colectomy for colon carcinoma. She also had osteoporosis, for which she started receiving IV infusion of zoledronic acid. One week following the administration of the IV infusion, she developed pain in both shoulders, spreading to arms, knees and hips, and was treated with unspecified systemic steroids. Several weeks after receiving the zoledronic acid, she showed musculoskeletal pain with ESR of 120 mm/hour. Subsequently, she was diagnosed with PMR. The 84-year-old woman developed autoimmune acquired haemophilia and immediate muscle pain, following the administration of zoledronic acid. She was recently diagnosed with breast cancer and started receiving IV infusion of zoledronic acid for osteoporosis. Immediately, she developed muscle pain which lasted for 9 days. Two months after the zoledronic acid infusion, she developed autoimmune acquired haemophilia and was treated with unspecified high dose corticosteroids. The 69-year-old woman developed PMR following the administration of zoledronic acid. She started receiving IV infusion of zoledronic acid for painful osteoarthritis of hands 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680

Journal

Reactions WeeklySpringer Journals

Published: Dec 2, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off